These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 16988391)

  • 21. Identifying and quantifying heterogeneity in high content analysis: application of heterogeneity indices to drug discovery.
    Gough AH; Chen N; Shun TY; Lezon TR; Boltz RC; Reese CE; Wagner J; Vernetti LA; Grandis JR; Lee AV; Stern AM; Schurdak ME; Taylor DL
    PLoS One; 2014; 9(7):e102678. PubMed ID: 25036749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Live mammalian cell arrays.
    Woodruff K; Fidalgo LM; Gobaa S; Lutolf MP; Maerkl SJ
    Nat Methods; 2013 Jun; 10(6):550-2. PubMed ID: 23644546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of human proteins that modify misfolding and proteotoxicity of pathogenic ataxin-1.
    Petrakis S; Raskó T; Russ J; Friedrich RP; Stroedicke M; Riechers SP; Muehlenberg K; Möller A; Reinhardt A; Vinayagam A; Schaefer MH; Boutros M; Tricoire H; Andrade-Navarro MA; Wanker EE
    PLoS Genet; 2012; 8(8):e1002897. PubMed ID: 22916034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An active role for machine learning in drug development.
    Murphy RF
    Nat Chem Biol; 2011 Jun; 7(6):327-30. PubMed ID: 21587249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression variation: its relevance to emergence of chronic disease and to therapy.
    Mayburd AL
    PLoS One; 2009 Jun; 4(6):e5921. PubMed ID: 19526064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A cheminformatic toolkit for mining biomedical knowledge.
    Rosania GR; Crippen G; Woolf P; States D; Shedden K
    Pharm Res; 2007 Oct; 24(10):1791-802. PubMed ID: 17385012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generating 'omic knowledge': the role of informatics in high content screening.
    Collins MA
    Comb Chem High Throughput Screen; 2009 Nov; 12(9):917-25. PubMed ID: 19531005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A personal perspective on high-content screening (HCS): from the beginning.
    Taylor DL
    J Biomol Screen; 2010 Aug; 15(7):720-5. PubMed ID: 20639498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overview of informatics for high content screening.
    Dunlay RT; Czekalski WJ; Collins MA
    Methods Mol Biol; 2007; 356():269-80. PubMed ID: 16988410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Live cell imaging: an industrial perspective.
    McCann T
    Methods Mol Biol; 2010; 591():47-66. PubMed ID: 19957123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Past, present, and future of high content screening and the field of cellomics.
    Taylor DL
    Methods Mol Biol; 2007; 356():3-18. PubMed ID: 16988391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Requirements, features, and performance of high content screening platforms.
    Gough AH; Johnston PA
    Methods Mol Biol; 2007; 356():41-61. PubMed ID: 16988394
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.